PRTG and hepatocellular carcinoma: In our study, the expression of GABRR1, GAGE2D, KCNH2, PRTG, SHC4, and SMIM32 was significantly correlated with OS of HCC, and the expression of GABRR1 and KCNH2 was associated with sorafenib treatment response.